Medications for Osteoarthritis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Osteoarthritis.
Found 21 Approved Drugs for Osteoarthritis
OxyCODONE
Brand Names
Endocet, Nalocet, Percocet, HYDROcodone APAP, HYDROcodone, Tencon, OxyContin, Roxicodone, Allzital, Homatropine Methylbromide, RoxyBond, Norco, Fioricet, Oxaydo, Hysingla, Xtampza, Butalbital, Butal, Ascomp
OxyCODONE
Brand Names
Endocet, Nalocet, Percocet, HYDROcodone APAP, HYDROcodone, Tencon, OxyContin, Roxicodone, Allzital, Homatropine Methylbromide, RoxyBond, Norco, Fioricet, Oxaydo, Hysingla, Xtampza, Butalbital, Butal, Ascomp
Form: Liquid, Tablet, Capsule, Solution
Method of administration: Oral
FDA approval date: December 07, 1983
Classification: Methylxanthine
Oxycodone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions.
Celecoxib
Brand Names
Elyxyb, Celebrex
Celecoxib
Brand Names
Elyxyb, Celebrex
Form: Capsule, Liquid
Method of administration: Oral
FDA approval date: October 02, 1998
Classification: Nonsteroidal Anti-inflammatory Drug
CELEBREX is indicated CELEBREX is a nonsteroidal anti-inflammatory drug indicated for: Osteoarthritis (OA).
MisoprostoL
Brand Names
Cytotec, MisoprostoL Diclofenac-Sodium-MisoprostoL, Dicloenac, Arthrotec, Diclofenac
MisoprostoL
Brand Names
Cytotec, MisoprostoL Diclofenac-Sodium-MisoprostoL, Dicloenac, Arthrotec, Diclofenac
Form: Tablet
Method of administration: Oral
FDA approval date: December 27, 1986
Classification: Nonsteroidal Anti-inflammatory Drug
Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions.
MethylPREDNISolone
Brand Names
Solu-Medrol MethylPREDNISolone, Solu-Medrol, Medrol
MethylPREDNISolone
Brand Names
Solu-Medrol MethylPREDNISolone, Solu-Medrol, Medrol
Form: Injection, Tablet
Method of administration: Oral, Intravenous, Intramuscular
FDA approval date: October 24, 1957
Classification: Corticosteroid
Methylprednisolone tablets are indicated in the following conditions: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) Ankylosing spondylitis Acute and subacute bursitis Synovitis of osteoarthritis Acute nonspecific tenosynovitis Post-traumatic osteoarthritis Psoriatic arthritis EpicondylitisAcute gouty arthritis Collagen Diseases During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus Systemic dermatomyositis (polymyositis) Acute rheumatic carditis Dermatologic Diseases Bullous dermatitis herpetiformis Severe erythema multiforme (Stevens-Johnson syndrome) Severe seborrheic dermatitis Exfoliative dermatitis Mycosis fungoides Pemphigus Severe psoriasis Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Serum sickness Contact dermatitis Bronchial asthma Atopic dermatitis Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic corneal marginal ulcers Herpes zoster ophthalmicus Anterior segment inflammation Diffuse posterior uveitis and choroiditis Sympathetic ophthalmia Keratitis Optic neuritis Allergic conjunctivitis Chorioretinitis Iritis and iridocyclitis Respiratory Diseases Symptomatic sarcoidosis Berylliosis Loeffler's syndrome not manageable by other means Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy Aspiration pneumonitis Hematologic Disorders Idiopathic thrombocytopenic purpura in adults Secondary thrombocytopenia in adults Acquired (autoimmune) hemolytic anemia Erythroblastopenia (RBC anemia) Congenital (erythroid) hypoplastic anemia Neoplastic Diseases For palliative management of: Leukemias and lymphomas in adults Acute leukemia of childhood Edematous States To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus. Gastrointestinal Diseases To tide the patient over a critical period of the disease in: Ulcerative colitis Regional enteritis Nervous System Acute exacerbations of multiple sclerosis Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Trichinosis with neurologic or myocardial involvement.
Meloxicam
Brand Names
Xifyrm, Symbravo
Meloxicam
Brand Names
Xifyrm, Symbravo
Form: Injection, Tablet, Suspension, Capsule
Method of administration: Oral, Intravenous
FDA approval date: November 01, 2005
Classification: Nonsteroidal Anti-inflammatory Drug
Carefully consider the potential benefits and risks of meloxicam and other treatment options before deciding to use meloxicam. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Meloxicam is indicated for relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis.
Showing 1-5 of 21
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances